about
New concepts of resistance in the treatment of Helicobacter pylori infectionsSequential versus standard triple first-line therapy forHelicobacter pylorieradicationProbiotics for the treatment of Helicobacter pylori infection in childrenHelicobacter pylori infection in older peopleReview article: bismuth-based therapy for Helicobacter pylori eradication in childrenStructural and Functional Analysis of Campylobacter jejuni PseG: A UDP-SUGAR HYDROLASE FROM THE PSEUDAMINIC ACID BIOSYNTHETIC PATHWAYA review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidenceMeta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?Prevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review."Concomitant" or "sequential" eradication of Helicobacter pylori: which regimen comes first?Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, PolandClinical trial report: Eradication of Helicobacter pylori reduces the risk for subsequent gastric cancer.Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and HelicobacterProbiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysisEfficacy of Clarithromycin Containing Bismuth-Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication.Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradicationHelicobacter pylori Eradication Therapy: Current Availabilities.Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.Recruiting the host's immune system to target Helicobacter pylori's surface glycans.Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.Optimal therapy for Helicobacter pylori infections.Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.Guidelines for treatment of Helicobacter pylori in the East and West.Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view.Current options for the treatment of Helicobacter pylori.A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).3rd Brazilian Consensus on Helicobacter pylori.Eradication of Helicobacter pylori infection: which regimen first?Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.Rescue Therapy for Helicobacter pylori Infection 2012.Advances in the treatment of Helicobacter pylori infection in children.Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population.Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
P2860
Q24622513-3F6FC6AD-11CB-46A7-89C3-84CC14C48AB0Q26471410-14A2E44B-798B-459C-B689-60523D3BDA4BQ26825005-5D7D54D1-8687-4108-8697-35C72AFFB793Q26853652-5D433B32-BA6F-49A9-AA43-0675BC4A2B09Q26998597-FCB1B1F8-2325-4656-B0AD-45ED7C8830FAQ27655695-26A5EFCC-FF81-498B-9021-5A55BCFFA510Q27687842-27CED513-0D21-47CA-A4F8-8D99E68C83F9Q28072552-1C96265B-C4EE-40BB-85AA-A718F3EF35BBQ28082104-5EA21B94-6596-4552-8F28-89E0F5BD425EQ30252088-118F71DC-87BB-41D2-8F7A-9AA99EC6B586Q33813453-FF877B84-CFC1-4D08-BC71-BD866091FC5DQ33935291-67B4F334-32F1-43DE-A17F-51B1A4510B9BQ34280623-77EAA406-C7AD-4138-A6B4-20FEBFADDC9DQ34713695-9C629155-774E-4486-9624-93D388DF8E51Q35375748-2340E9CE-6CF3-4BF9-BAFB-9922A26241A3Q35603883-EE0750B4-9CFB-4CD8-9C31-542910457ABAQ35771863-5232BFB0-9ABF-4580-ACDA-675B90894045Q35841617-A34D6C41-C73D-4F09-88E6-782CCF81847DQ35843088-EDA4E86D-949E-4A74-9AEE-7BC12C4C6D38Q36148148-7F2A0BA3-00B2-49C6-83A1-7CC961205F0DQ36357419-D2DFECDB-F2E1-4492-824D-3020FE4A8BEDQ36556466-2F6095B2-9EA2-4D81-B5E8-454374EA36D1Q37206354-DEFA5958-85C1-4BB3-8BF9-CE9ADA350D73Q37317503-5F0BF6EA-2F0E-4675-A74D-7C79484D01ABQ37835707-09E52D29-30E0-4AC8-8616-03D3596D8692Q37899929-85CC369C-194E-41CA-8373-BA0165A3E194Q37912220-A67E86D1-5447-4E72-A832-777D56552896Q37933455-42271DA7-1D09-4D0A-B18C-2A31D3C72863Q38075061-D3A8FD42-816D-440B-B852-EC3745CE8702Q38093864-17655269-2B33-4144-AAC0-C9C3D7D9B47BQ38113105-24F58034-CBBB-45A8-9EDD-02A0DE2996BAQ38191565-2D427241-42E8-4C8E-B3D6-03A077A5B103Q38219028-3BFA5BF8-DDF9-448B-8A0F-55025CD68A46Q38238745-2B6A4041-84D1-4836-A447-C6BA1D0E960CQ39588933-E0B86CD9-AD6A-4D5A-BD53-3AD74876BF55Q41016205-EB91360F-EF13-4F2E-8056-E47E6D54A5D4Q42129420-5BCF9F52-F5DE-4CC9-9D3C-80B74C744C20Q43100513-3FD432F9-3241-4E37-AB84-40A518B0B81EQ43896137-FC6C1EB8-395C-48EA-BEBA-903549252B46Q44115534-8C81DF0B-9E72-4E55-90BC-9679B658996C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Helicobacter pylori and antibiotic resistance.
@en
Helicobacter pylori and antibiotic resistance.
@nl
type
label
Helicobacter pylori and antibiotic resistance.
@en
Helicobacter pylori and antibiotic resistance.
@nl
prefLabel
Helicobacter pylori and antibiotic resistance.
@en
Helicobacter pylori and antibiotic resistance.
@nl
P2860
P356
P1433
P1476
Helicobacter pylori and antibiotic resistance.
@en
P2093
Francis Megraud
P2860
P356
10.1136/GUT.2007.132514
P407
P577
2007-11-01T00:00:00Z